Pulmonary Rehabilitation in Asthma Control

Asthma Clinical Trial

Official title:

Does Pulmonary Rehabilitation Contribute to Asthma Control?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03227341
• Other study ID #: KCU123
• Status: Completed
• Phase: N/A
• First received: July 20, 2017
• Last updated: July 21, 2017
• Start date: January 1, 2013
• Est. completion date: January 1, 2017

Study information

• Verified date: July 2017
• Source: Izmir Katip Celebi University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators compared the effectiveness of pulmonary rehabilitation program on asthma control in patients with uncontrolled and partially controlled asthma.

Description:

Asthma treatment is not only medical, it also requires a comprehensive care including nonpharmacological treatment. Pulmonary rehabilitation represents the most important part of the comprehensive care. The investigators aimed to evaluate the efficacy of pulmonary rehabilitation in patients with uncontrolled and partially controlled asthma.

Asthma patients referred to pulmonary rehabilitation (PR) unit were classified according to asthma control test; as partially controlled patients (Group 1), and as uncontrolled patients (Group 2). All patients received of a 8 week pulmonary rehabilitation program. Asthma control tests, pulmonary function tests, arterial blood gases analysis, dyspnea perception, quality of life, exercise capacity, anxiety and depression assessments were performed before and after pulmonary rehabilitation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: January 1, 2017
• Est. primary completion date: January 1, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Asthmatic patients referred from the outpatient clinic to Pulmonary Rehabilitation unit was confirmed according to GINA guidelines

Exclusion Criteria:

• If the initial diagnosis cannot be confirmed, the patient excluded from the study

• Patients were under medical treatment of -6 months and considered clinically stable.

• Patients with cardiovascular, other lung diseases (pneumoconiosis, pulmonary tuberculosis, interstitial lung disease), or musculoskeletal diseases that would impair exercise training were excluded from the study.

• Also subjects with lack of motivation, poor compliance (not attending the program more than 2 times) or having transport problems were excluded from the study

Related Conditions & MeSH terms

• Asthma

Intervention

Other:
• Exercise
8 week exercise program including breathing exercises consisted of pursed-lip breathing, diaphragmatic breathing and thoracic expansion exercises, relaxation and stretching exercises, upper and lower extremity muscle strength training, and aerobic exercises. In addition, bronchial hygiene techniques and dyspnea-reducing positions

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Izmir Katip Celebi University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Asthma control test score	A test measured the control of asthma	4 weeks
Secondary	Exercise capacity	Six minute walk test	6 minute
Secondary	Dyspnea	MMRC Dyspnea Scale	1 year
Secondary	Quality of Life	St. George Respiratory Questionnaire	1 year
Secondary	Pulmonary Function Test	FEV1, FVC, DLCO	1 hour
Secondary	Arterial Blood Gas	PaO2, PaCO2, SaO2	1 hour
Secondary	Anxiety and Depression	Hospital Anxiety and Depression Scale	1 week